Review · Nault et al., Cochrane (2024)
Cochrane Review on Zinc for Preventing and Treating the Common Cold(opens in a new tab)
- Findings and study population
- Evaluating 34 trials (8,526 participants: 15 prevention, 19 treatment), zinc had little or no preventive effect. Treatment trials (8 studies, 972 participants) suggested shortened cold duration (MD −2.37 days, 95% CI −4.21 to −0.53), but certainty was low with high heterogeneity (I2=97%) and more nonserious adverse events like nausea.
- Limitations and differences from this claim
- Substantial heterogeneity in formulations (largely lozenges) and doses. It does not establish a universal benefit or support high-dose self-treatment.
Checked: